ETNB Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-03-01 | Atkinson Edward Morrow III | director | 20,000 | M-Exempt | D | 10,000 | 4.44 | 44,400.00 |
2023-03-01 | Atkinson Edward Morrow III | director | 0 | S-Sale | D | 10,000 | 13.60 | 136,000.00 |
2023-03-01 | Atkinson Edward Morrow III | director | 10,000 | M-Exempt | A | 10,000 | 4.44 | 44,400.00 |
2023-02-21 | Martins Ryan | officer: Chief Financial Officer | 58,578 | S-Sale | D | 2,540 | 13.89 | 35,280.60 |
2023-02-17 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 284,072 | F-InKind | D | 6,279 | 13.97 | 87,717.63 |
2023-02-17 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 91,179 | F-InKind | D | 2,140 | 13.97 | 29,895.80 |
2023-02-17 | Mansbach Harry H | officer: Chief Medical Officer | 94,671 | F-InKind | D | 2,127 | 13.97 | 29,714.19 |
2023-02-17 | Martins Ryan | officer: Chief Financial Officer | 61,118 | F-InKind | D | 1,750 | 13.97 | 24,447.50 |
2023-02-09 | Altschuler Steven | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | Zoth Lota S. | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 300,000 | A-Award | A | 300,000 | 14.70 | 4,410,000.00 |
2023-02-09 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 290,351 | A-Award | A | 75,000 | 0.00 | 0.00 |
2023-02-09 | Mansbach Harry H | officer: Chief Medical Officer | 120,000 | A-Award | A | 120,000 | 14.70 | 1,764,000.00 |
2023-02-09 | Mansbach Harry H | officer: Chief Medical Officer | 96,798 | A-Award | A | 30,000 | 0.00 | 0.00 |
2023-02-09 | Martins Ryan | officer: Chief Financial Officer | 110,000 | A-Award | A | 110,000 | 14.70 | 1,617,000.00 |
2023-02-09 | Martins Ryan | officer: Chief Financial Officer | 62,868 | A-Award | A | 30,000 | 0.00 | 0.00 |
2023-02-09 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 120,000 | A-Award | A | 120,000 | 14.70 | 1,764,000.00 |
2023-02-09 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 93,319 | A-Award | A | 30,000 | 0.00 | 0.00 |
2023-02-09 | DiRocco Derek | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | Atkinson Edward Morrow III | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | Hayden Michael R | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | Grunberg Gregory | director, 10 percent owner | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-09 | LAPORTE KATHLEEN | director | 27,400 | A-Award | A | 27,400 | 14.70 | 402,780.00 |
2023-02-08 | Martins Ryan | officer: Chief Financial Officer | 32,868 | S-Sale | D | 1,480 | 14.41 | 21,326.80 |
2023-02-05 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 63,319 | F-InKind | D | 1,390 | 13.24 | 18,403.60 |
2023-02-05 | Martins Ryan | officer: Chief Financial Officer | 34,348 | F-InKind | D | 592 | 13.24 | 7,838.08 |
2023-02-05 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 215,351 | F-InKind | D | 4,078 | 13.24 | 53,992.72 |
2023-02-05 | Mansbach Harry H | officer: Chief Medical Officer | 66,798 | F-InKind | D | 1,360 | 13.24 | 18,006.40 |
2023-02-03 | Martins Ryan | officer: Chief Financial Officer | 81,901 | M-Exempt | D | 3,000 | 3.11 | 9,330.00 |
2023-02-03 | Martins Ryan | officer: Chief Financial Officer | 35,368 | S-Sale | D | 592 | 12.70 | 7,518.40 |
2023-02-03 | Martins Ryan | officer: Chief Financial Officer | 38,960 | S-Sale | D | 3,000 | 13.11 | 39,330.00 |
2023-02-03 | Martins Ryan | officer: Chief Financial Officer | 38,960 | M-Exempt | A | 3,000 | 3.11 | 9,330.00 |
2023-02-01 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 64,709 | F-InKind | D | 695 | 12.05 | 8,374.75 |
2023-02-01 | Mansbach Harry H | officer: Chief Medical Officer | 68,158 | F-InKind | D | 680 | 12.05 | 8,194.00 |
2023-02-01 | Martins Ryan | officer: Chief Financial Officer | 35,960 | F-InKind | D | 408 | 12.05 | 4,916.40 |
2023-01-03 | Martins Ryan | officer: Chief Financial Officer | 36,368 | S-Sale | D | 5,947 | 12.51 | 74,396.97 |
2022-11-15 | Mansbach Harry H | officer: Chief Medical Officer | 68,838 | F-InKind | D | 3,113 | 9.79 | 30,476.27 |
2022-11-15 | Mansbach Harry H | officer: Chief Medical Officer | 71,951 | A-Award | A | 9,000 | 0.00 | 0.00 |
2022-10-18 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner | 8,955,410 | P-Purchase | A | 1,172,741 | 7.65 | 8,971,468.65 |
2022-09-30 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 65,404 | F-InKind | D | 1,297 | 5.79 | 7,509.63 |
2022-09-30 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 66,701 | A-Award | A | 3,750 | 0.00 | 0.00 |
2022-09-28 | Martins Ryan | officer: Chief Financial Officer | 42,315 | F-InKind | D | 2,018 | 5.76 | 11,623.68 |
2022-09-28 | Martins Ryan | officer: Chief Financial Officer | 44,333 | A-Award | A | 5,833 | 0.00 | 0.00 |
2022-09-28 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 62,951 | F-InKind | D | 2,882 | 5.76 | 16,600.32 |
2022-09-28 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 65,833 | A-Award | A | 8,333 | 0.00 | 0.00 |
2022-09-28 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 219,429 | F-InKind | D | 11,527 | 5.76 | 66,395.52 |
2022-09-28 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 230,956 | A-Award | A | 33,333 | 0.00 | 0.00 |
2022-09-28 | Mansbach Harry H | officer: Chief Medical Officer | 62,951 | F-InKind | D | 2,882 | 5.76 | 16,600.32 |
2022-09-28 | Mansbach Harry H | officer: Chief Medical Officer | 65,833 | A-Award | A | 8,333 | 0.00 | 0.00 |
2022-09-09 | Mansbach Harry H | officer: Chief Medical Officer | 57,500 | A-Award | A | 25,000 | 0.00 | 0.00 |
2022-09-09 | Martins Ryan | officer: Chief Financial Officer | 38,500 | A-Award | A | 15,000 | 0.00 | 0.00 |
2022-09-09 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 57,500 | A-Award | A | 25,000 | 0.00 | 0.00 |
2022-09-08 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 225,231 | M-Exempt | D | 100,000 | 1.93 | 193,000.00 |
2022-09-08 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 197,623 | M-Exempt | A | 100,000 | 1.93 | 193,000.00 |
2022-07-01 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner | 1,408,450 | P-Purchase | A | 2,816,900 | 5.33 | 14,999,992.50 |
2022-07-01 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner | 7,782,669 | P-Purchase | A | 2,816,900 | 3.55 | 9,999,995.00 |
2022-05-25 | Atkinson Edward Morrow III | director | 6,250 | A-Award | A | 6,250 | 2.61 | 16,312.50 |
2022-05-16 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | Hayden Michael R | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | DiRocco Derek | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | Zoth Lota S. | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | Altschuler Steven | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | Grunberg Gregory | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-05-16 | LAPORTE KATHLEEN | director | 25,000 | A-Award | A | 25,000 | 2.64 | 66,000.00 |
2022-02-17 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 220,000 | A-Award | A | 220,000 | 4.44 | 976,800.00 |
2022-02-17 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 100,045 | A-Award | A | 54,200 | 0.00 | 0.00 |
2022-02-17 | Mansbach Harry H | officer: Chief Medical Officer | 70,000 | A-Award | A | 70,000 | 4.44 | 310,800.00 |
2022-02-17 | Mansbach Harry H | officer: Chief Medical Officer | 32,500 | A-Award | A | 5,000 | 0.00 | 0.00 |
2022-02-17 | Mansbach Harry H | officer: Chief Medical Officer | 27,500 | A-Award | A | 17,500 | 0.00 | 0.00 |
2022-02-17 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 70,000 | A-Award | A | 70,000 | 4.44 | 310,800.00 |
2022-02-17 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 32,500 | A-Award | A | 5,000 | 0.00 | 0.00 |
2022-02-17 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 27,500 | A-Award | A | 17,500 | 0.00 | 0.00 |
2022-02-17 | Martins Ryan | officer: Chief Financial Officer | 52,000 | A-Award | A | 52,000 | 4.44 | 230,880.00 |
2022-02-17 | Martins Ryan | officer: Chief Financial Officer | 23,500 | A-Award | A | 3,000 | 0.00 | 0.00 |
2022-02-17 | Martins Ryan | officer: Chief Financial Officer | 20,500 | A-Award | A | 13,000 | 0.00 | 0.00 |
2022-02-17 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 25,000 | A-Award | A | 25,000 | 4.44 | 111,000.00 |
2022-02-17 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 8,750 | A-Award | A | 2,500 | 0.00 | 0.00 |
2022-02-17 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 6,250 | A-Award | A | 6,250 | 0.00 | 0.00 |
2022-02-05 | Le-Nguyen Quoc | officer: Chief Technical Operations Officer and Head of Quality | 31,137 | F-InKind | D | 1,363 | 5.23 | 7,128.49 |
2022-02-05 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 95,957 | F-InKind | D | 4,088 | 5.23 | 21,380.24 |
2022-02-05 | Martins Ryan | officer: Chief Financial Officer | 22,478 | F-InKind | D | 1,022 | 5.23 | 5,345.06 |
2022-02-05 | Mansbach Harry H | officer: Chief Medical Officer | 31,137 | F-InKind | D | 1,363 | 5.23 | 7,128.49 |
2022-02-01 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 3,106 | M-Exempt | D | 3,000 | 1.93 | 5,790.00 |
2022-02-01 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 14,203 | M-Exempt | D | 4,000 | 1.93 | 7,720.00 |
2022-02-01 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 0 | S-Sale | D | 7,000 | 5.70 | 39,900.00 |
2022-02-01 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 7,000 | M-Exempt | A | 3,000 | 1.93 | 5,790.00 |
2022-02-01 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 4,000 | M-Exempt | A | 4,000 | 1.93 | 7,720.00 |
2022-01-28 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 45,845 | P-Purchase | A | 2,500 | 6.14 | 15,350.00 |
2022-01-27 | PALEKAR ROHAN | director, officer: Chief Executive Officer | 43,345 | P-Purchase | A | 5,000 | 7.50 | 37,500.00 |
2022-01-26 | ORBIMED ADVISORS LLC | 10 percent owner | 1,829,436 | S-Sale | D | 10,740 | 8.38 | 90,001.20 |
2022-01-26 | ORBIMED ADVISORS LLC | 10 percent owner | 1,829,433 | S-Sale | D | 10,742 | 8.38 | 90,017.96 |
2022-01-25 | ORBIMED ADVISORS LLC | 10 percent owner | 1,840,176 | S-Sale | D | 24,545 | 8.40 | 206,178.00 |
2022-01-25 | ORBIMED ADVISORS LLC | 10 percent owner | 1,840,175 | S-Sale | D | 24,546 | 8.40 | 206,186.40 |
2021-12-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 6,106 | M-Exempt | D | 7,000 | 1.93 | 13,510.00 |
2021-12-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 0 | S-Sale | D | 7,000 | 11.48 | 80,360.00 |
2021-12-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 7,000 | M-Exempt | A | 7,000 | 1.93 | 13,510.00 |
2021-11-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 18,203 | M-Exempt | D | 7,000 | 1.93 | 13,510.00 |
2021-11-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 0 | S-Sale | D | 7,000 | 16.49 | 115,430.00 |
2021-11-16 | Waisbourd Ram | officer: Chief Operating Officer and Chief Business Officer | 7,000 | M-Exempt | A | 7,000 | 1.93 | 13,510.00 |
2021-11-01 | LAPORTE KATHLEEN | director | 25,000 | A-Award | A | 25,000 | 18.68 | 467,000.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.